Trilegal, one of India’s leading law firms, has strengthened its life sciences and healthcare capabilities with the addition of seasoned lawyer Ashwin Sapra as an Equity Partner in the corporate practice. Ashwin brings over 25 years of domestic and international experience advising clients across the healthcare, pharmaceutical, medical device, diagnostics and life sciences sectors. With his joining, Trilegal’s partnership strength will increase to 151, reflecting its continued focus on building sector-specialised expertise.
Ashwin Sapra joins from Cyril Amarchand Mangaldas, where he headed their Pharma and Life Sciences practice.
As private capital, digital health initiatives, and regulatory reforms reshape India’s healthcare and life sciences sector, Trilegal’s strengthened leadership enhances its capabilities to advise industry participants and investors in navigating this evolving environment.
Commenting on the appointment, Nishant Parikh and Sridhar Gorthi, Partners and Members of the Management Committee at Trilegal, said, “Ashwin is a highly seasoned practitioner whose experience aligns well with the firm’s integrated, cross-practice model. He will play a key role in the firm’s rapidly growing healthcare, pharmaceutical, medical device and life sciences capabilities, adding depth and expertise to our client advisory competencies across transactional, disputes, regulatory, and intellectual property matters.”
On his joining, Ashwin Sapra said, “The healthcare sector in India is at an important stage of growth, with increased investment activity and regulatory engagement. Trilegal’s integrated platform, sector focus, and global standing provide an opportunity to work closely with clients on their most critical legal and business issues. I look forward to working with the team to support healthcare and life sciences clients across mandates.”
